申请人:——
公开号:US20040019046A1
公开(公告)日:2004-01-29
Phenylacetamido-pyrazoles and, more particularly, N-(5-cycloalkyl-1H-pyrazol-3-yl)phenylacetamido derivatives, optionally further substituted as reported in the description; or pharmaceutically acceptable salts thereof; are useful in the treatment of cell proliferative disorders, e.g. cancer, associated with an altered cell cycle dependent kinase activity.
苯乙酰胺基吡唑,更具体地说,是N-(5-环烷基-1H-吡唑-3-基)苯乙酰胺衍生物,可选择性地进一步取代,如描述所述;或其药学上可接受的盐;在治疗与细胞周期依赖性激酶活性改变相关的细胞增殖性疾病,例如癌症方面有用。